> top > projects > spacy-test > docs > PubMed:3920729 > annotations
spacy-test Home  

PubMed:3920729 JSONTXT 3 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
spaCy_T0 0-7 NNPS denotes Effects
spaCy_T1 8-10 IN denotes of
spaCy_T2 11-31 JJ denotes 6-keto-prostaglandin
spaCy_T3 32-34 NN denotes E1
spaCy_T4 35-37 IN denotes on
spaCy_T5 38-45 JJ denotes ascitic
spaCy_T6 46-58 NN denotes hepatoma-130
spaCy_T7 59-61 IN denotes in
spaCy_T8 62-66 NN denotes vivo
spaCy_T9 67-77 NN denotes comparison
spaCy_T10 78-82 IN denotes with
spaCy_T11 83-99 JJ denotes chemotherapeutic
spaCy_T12 100-106 NNS denotes agents
spaCy_T13 106-107 . denotes .
spaCy_T14 108-111 DT denotes The
spaCy_T15 112-122 JJ denotes inhibitory
spaCy_T16 123-129 NN denotes effect
spaCy_T17 130-132 IN denotes of
spaCy_T18 133-153 JJ denotes 6-keto-prostaglandin
spaCy_T19 154-156 CD denotes E1
spaCy_T20 157-158 -LRB- denotes (
spaCy_T21 158-162 NN denotes pGE1
spaCy_T22 162-163 -RRB- denotes )
spaCy_T23 164-166 IN denotes on
spaCy_T24 167-170 DT denotes the
spaCy_T25 171-177 NN denotes growth
spaCy_T26 178-181 CC denotes and
spaCy_T27 182-190 NN denotes survival
spaCy_T28 191-193 IN denotes of
spaCy_T29 194-201 JJ denotes ascitic
spaCy_T30 202-210 NN denotes hepatoma
spaCy_T31 211-212 -LRB- denotes (
spaCy_T32 212-218 NNP denotes AH-130
spaCy_T33 218-219 -RRB- denotes )
spaCy_T34 220-225 NNS denotes cells
spaCy_T35 226-228 IN denotes in
spaCy_T36 229-233 NN denotes vivo
spaCy_T37 234-237 VBD denotes was
spaCy_T38 238-246 VBN denotes compared
spaCy_T39 247-251 IN denotes with
spaCy_T40 252-261 RB denotes currently
spaCy_T41 262-266 VBN denotes used
spaCy_T42 267-283 JJ denotes chemotherapeutic
spaCy_T43 284-290 NNS denotes agents
spaCy_T44 290-291 . denotes .
spaCy_T45 292-297 CD denotes Three
spaCy_T46 298-302 NNS denotes days
spaCy_T47 303-308 IN denotes after
spaCy_T48 309-318 VBG denotes receiving
spaCy_T49 319-321 DT denotes an
spaCy_T50 322-337 JJ denotes intraperitoneal
spaCy_T51 338-347 NN denotes injection
spaCy_T52 348-350 IN denotes of
spaCy_T53 351-352 CD denotes 3
spaCy_T54 353-354 NNP denotes X
spaCy_T55 355-357 CD denotes 10
spaCy_T56 357-358 -LRB- denotes (
spaCy_T57 358-359 CD denotes 6
spaCy_T58 359-360 -RRB- denotes )
spaCy_T59 361-367 NN denotes AH-130
spaCy_T60 368-373 NN denotes tumor
spaCy_T61 374-379 NNS denotes cells
spaCy_T62 379-380 , denotes ,
spaCy_T63 381-388 NNP denotes Donrhyu
spaCy_T64 389-393 NNS denotes rats
spaCy_T65 394-398 VBD denotes were
spaCy_T66 399-407 VBN denotes injected
spaCy_T67 408-421 RB denotes intravenously
spaCy_T68 422-424 CC denotes or
spaCy_T69 425-442 RB denotes intraperitoneally
spaCy_T70 443-447 IN denotes with
spaCy_T71 448-451 CD denotes one
spaCy_T72 452-454 IN denotes of
spaCy_T73 455-458 DT denotes the
spaCy_T74 459-468 NN denotes following
spaCy_T75 468-469 : denotes :
spaCy_T76 470-481 NNP denotes Thromboxane
spaCy_T77 482-484 NN denotes B2
spaCy_T78 485-486 -LRB- denotes (
spaCy_T79 486-490 CD denotes TXB2
spaCy_T80 490-491 -RRB- denotes )
spaCy_T81 492-493 -LRB- denotes (
spaCy_T82 493-496 CD denotes 0.5
spaCy_T83 497-502 NN denotes mg/kg
spaCy_T84 502-503 -RRB- denotes )
spaCy_T85 503-504 , denotes ,
spaCy_T86 505-516 NNP denotes 6-keto-pGE1
spaCy_T87 517-518 -LRB- denotes (
spaCy_T88 518-521 CD denotes 0.5
spaCy_T89 522-527 NN denotes mg/kg
spaCy_T90 527-528 -RRB- denotes )
spaCy_T91 528-529 , denotes ,
spaCy_T92 530-539 NNP denotes Mitomycin
spaCy_T93 540-541 NNP denotes C
spaCy_T94 542-543 -LRB- denotes (
spaCy_T95 543-546 NNP denotes MMC
spaCy_T96 546-547 -RRB- denotes )
spaCy_T97 548-549 -LRB- denotes (
spaCy_T98 549-552 CD denotes 1.5
spaCy_T99 553-558 NN denotes mg/kg
spaCy_T100 558-559 -RRB- denotes )
spaCy_T101 559-560 , denotes ,
spaCy_T102 561-563 CC denotes or
spaCy_T103 564-567 NNP denotes MMC
spaCy_T104 568-569 VBP denotes +
spaCy_T105 570-581 JJ denotes 6-keto-pGE1
spaCy_T106 582-583 -LRB- denotes (
spaCy_T107 583-586 CD denotes 1.5
spaCy_T108 587-592 JJ denotes mg/kg
spaCy_T109 593-594 NN denotes +
spaCy_T110 595-598 CD denotes 0.5
spaCy_T111 599-604 NN denotes mg/kg
spaCy_T112 604-605 -RRB- denotes )
spaCy_T113 605-606 . denotes .
spaCy_T114 607-610 DT denotes The
spaCy_T115 611-615 JJ denotes mean
spaCy_T116 616-624 NN denotes survival
spaCy_T117 625-629 NN denotes time
spaCy_T118 629-630 , denotes ,
spaCy_T119 631-637 NN denotes median
spaCy_T120 638-646 NN denotes survival
spaCy_T121 647-651 NN denotes time
spaCy_T122 651-652 , denotes ,
spaCy_T123 653-656 CC denotes and
spaCy_T124 657-665 NN denotes increase
spaCy_T125 666-668 IN denotes of
spaCy_T126 669-673 NN denotes life
spaCy_T127 674-682 NN denotes survival
spaCy_T128 683-690 NN denotes percent
spaCy_T129 691-692 -LRB- denotes (
spaCy_T130 692-695 CD denotes ILS
spaCy_T131 695-696 NN denotes %
spaCy_T132 696-697 -RRB- denotes )
spaCy_T133 698-704 IN denotes during
spaCy_T134 705-706 DT denotes a
spaCy_T135 707-709 CD denotes 60
spaCy_T136 710-713 NN denotes day
spaCy_T137 714-720 NN denotes period
spaCy_T138 721-729 VBD denotes revealed
spaCy_T139 730-734 IN denotes that
spaCy_T140 735-739 DT denotes both
spaCy_T141 740-751 JJ denotes 6-keto-pGE1
spaCy_T142 752-755 CC denotes and
spaCy_T143 756-767 JJ denotes 6-keto-pGE1
spaCy_T144 768-769 NN denotes +
spaCy_T145 770-773 NNP denotes MMC
spaCy_T146 774-787 RB denotes significantly
spaCy_T147 788-797 VBD denotes inhibited
spaCy_T148 798-804 NNP denotes AH-130
spaCy_T149 805-810 NN denotes tumor
spaCy_T150 811-815 NN denotes cell
spaCy_T151 816-822 NN denotes growth
spaCy_T152 822-823 , denotes ,
spaCy_T153 824-829 IN denotes while
spaCy_T154 830-834 CD denotes TXB2
spaCy_T155 835-843 VBN denotes promoted
spaCy_T156 844-849 NN denotes tumor
spaCy_T157 850-854 NN denotes cell
spaCy_T158 855-861 NN denotes growth
spaCy_T159 861-862 . denotes .
spaCy_T160 863-865 PRP denotes We
spaCy_T161 866-874 VBP denotes conclude
spaCy_T162 875-879 DT denotes that
spaCy_T163 880-891 NN denotes 6-keto-pGE1
spaCy_T164 892-896 IN denotes like
spaCy_T165 897-907 JJ denotes anti-tumor
spaCy_T166 908-914 NNS denotes agents
spaCy_T167 915-919 JJ denotes such
spaCy_T168 920-922 IN denotes as
spaCy_T169 923-926 NNP denotes MMC
spaCy_T170 926-927 , denotes ,
spaCy_T171 928-942 NNP denotes Diketocoriolin
spaCy_T172 943-944 NNP denotes B
spaCy_T173 944-945 , denotes ,
spaCy_T174 946-960 NNP denotes Carbazilquinon
spaCy_T175 960-961 , denotes ,
spaCy_T176 962-969 NNP denotes Endoxan
spaCy_T177 969-970 , denotes ,
spaCy_T178 971-974 CC denotes and
spaCy_T179 975-989 NNP denotes 5-Fluorouracil
spaCy_T180 989-990 , denotes ,
spaCy_T181 991-994 MD denotes can
spaCy_T182 995-1008 RB denotes significantly
spaCy_T183 1009-1016 VB denotes inhibit
spaCy_T184 1017-1023 NN denotes growth
spaCy_T185 1024-1026 IN denotes of
spaCy_T186 1027-1033 NNP denotes AH-130
spaCy_T187 1034-1039 NN denotes tumor
spaCy_T188 1040-1045 NNS denotes cells
spaCy_T189 1046-1048 IN denotes in
spaCy_T190 1049-1053 NN denotes vivo
spaCy_T191 1053-1054 , denotes ,
spaCy_T192 1055-1067 RB denotes particularly
spaCy_T193 1068-1072 WRB denotes when
spaCy_T194 1073-1085 VBN denotes administered
spaCy_T195 1086-1088 IN denotes in
spaCy_T196 1089-1100 NN denotes combination
spaCy_T197 1101-1105 IN denotes with
spaCy_T198 1106-1109 DT denotes the
spaCy_T199 1110-1120 JJ denotes anti-tumor
spaCy_T200 1121-1126 NN denotes agent
spaCy_T201 1127-1130 NNP denotes MMC
spaCy_T202 1130-1131 . denotes .
spaCy_R0 spaCy_T0 spaCy_T0 ROOT Effects,Effects
spaCy_R1 spaCy_T1 spaCy_T0 prep of,Effects
spaCy_R10 spaCy_T10 spaCy_T9 prep with,comparison
spaCy_R100 spaCy_T100 spaCy_T99 punct ),mg/kg
spaCy_R101 spaCy_T101 spaCy_T93 punct ",",C
spaCy_R102 spaCy_T102 spaCy_T93 cc or,C
spaCy_R103 spaCy_T103 spaCy_T93 conj MMC,C
spaCy_R104 spaCy_T104 spaCy_T105 compound +,6-keto-pGE1
spaCy_R105 spaCy_T105 spaCy_T74 appos 6-keto-pGE1,following
spaCy_R106 spaCy_T106 spaCy_T109 punct (,+
spaCy_R107 spaCy_T107 spaCy_T109 nummod 1.5,+
spaCy_R108 spaCy_T108 spaCy_T109 amod mg/kg,+
spaCy_R109 spaCy_T109 spaCy_T105 appos +,6-keto-pGE1
spaCy_R11 spaCy_T11 spaCy_T12 amod chemotherapeutic,agents
spaCy_R110 spaCy_T110 spaCy_T111 nummod 0.5,mg/kg
spaCy_R111 spaCy_T111 spaCy_T109 appos mg/kg,+
spaCy_R112 spaCy_T112 spaCy_T109 punct ),+
spaCy_R113 spaCy_T113 spaCy_T66 punct .,injected
spaCy_R114 spaCy_T114 spaCy_T117 det The,time
spaCy_R115 spaCy_T115 spaCy_T117 amod mean,time
spaCy_R116 spaCy_T116 spaCy_T117 compound survival,time
spaCy_R117 spaCy_T117 spaCy_T138 nsubj time,revealed
spaCy_R118 spaCy_T118 spaCy_T117 punct ",",time
spaCy_R119 spaCy_T119 spaCy_T121 compound median,time
spaCy_R12 spaCy_T12 spaCy_T10 pobj agents,with
spaCy_R120 spaCy_T120 spaCy_T121 compound survival,time
spaCy_R121 spaCy_T121 spaCy_T117 appos time,time
spaCy_R122 spaCy_T122 spaCy_T121 punct ",",time
spaCy_R123 spaCy_T123 spaCy_T121 cc and,time
spaCy_R124 spaCy_T124 spaCy_T121 conj increase,time
spaCy_R125 spaCy_T125 spaCy_T124 prep of,increase
spaCy_R126 spaCy_T126 spaCy_T127 compound life,survival
spaCy_R127 spaCy_T127 spaCy_T128 compound survival,percent
spaCy_R128 spaCy_T128 spaCy_T125 pobj percent,of
spaCy_R129 spaCy_T129 spaCy_T128 punct (,percent
spaCy_R13 spaCy_T13 spaCy_T0 punct .,Effects
spaCy_R130 spaCy_T130 spaCy_T131 nummod ILS,%
spaCy_R131 spaCy_T131 spaCy_T128 appos %,percent
spaCy_R132 spaCy_T132 spaCy_T128 punct ),percent
spaCy_R133 spaCy_T133 spaCy_T117 prep during,time
spaCy_R134 spaCy_T134 spaCy_T137 det a,period
spaCy_R135 spaCy_T135 spaCy_T136 nummod 60,day
spaCy_R136 spaCy_T136 spaCy_T137 compound day,period
spaCy_R137 spaCy_T137 spaCy_T133 pobj period,during
spaCy_R138 spaCy_T138 spaCy_T138 ROOT revealed,revealed
spaCy_R139 spaCy_T139 spaCy_T147 mark that,inhibited
spaCy_R14 spaCy_T14 spaCy_T16 det The,effect
spaCy_R140 spaCy_T140 spaCy_T141 preconj both,6-keto-pGE1
spaCy_R141 spaCy_T141 spaCy_T145 amod 6-keto-pGE1,MMC
spaCy_R142 spaCy_T142 spaCy_T141 cc and,6-keto-pGE1
spaCy_R143 spaCy_T143 spaCy_T141 conj 6-keto-pGE1,6-keto-pGE1
spaCy_R144 spaCy_T144 spaCy_T145 compound +,MMC
spaCy_R145 spaCy_T145 spaCy_T147 nsubj MMC,inhibited
spaCy_R146 spaCy_T146 spaCy_T147 advmod significantly,inhibited
spaCy_R147 spaCy_T147 spaCy_T138 ccomp inhibited,revealed
spaCy_R148 spaCy_T148 spaCy_T151 compound AH-130,growth
spaCy_R149 spaCy_T149 spaCy_T150 compound tumor,cell
spaCy_R15 spaCy_T15 spaCy_T16 amod inhibitory,effect
spaCy_R150 spaCy_T150 spaCy_T151 compound cell,growth
spaCy_R151 spaCy_T151 spaCy_T147 dobj growth,inhibited
spaCy_R152 spaCy_T152 spaCy_T147 punct ",",inhibited
spaCy_R153 spaCy_T153 spaCy_T158 mark while,growth
spaCy_R154 spaCy_T154 spaCy_T158 nummod TXB2,growth
spaCy_R155 spaCy_T155 spaCy_T158 amod promoted,growth
spaCy_R156 spaCy_T156 spaCy_T157 compound tumor,cell
spaCy_R157 spaCy_T157 spaCy_T158 compound cell,growth
spaCy_R158 spaCy_T158 spaCy_T147 advcl growth,inhibited
spaCy_R159 spaCy_T159 spaCy_T138 punct .,revealed
spaCy_R16 spaCy_T16 spaCy_T38 nsubjpass effect,compared
spaCy_R160 spaCy_T160 spaCy_T161 nsubj We,conclude
spaCy_R161 spaCy_T161 spaCy_T161 ROOT conclude,conclude
spaCy_R162 spaCy_T162 spaCy_T183 mark that,inhibit
spaCy_R163 spaCy_T163 spaCy_T183 nsubj 6-keto-pGE1,inhibit
spaCy_R164 spaCy_T164 spaCy_T163 prep like,6-keto-pGE1
spaCy_R165 spaCy_T165 spaCy_T166 amod anti-tumor,agents
spaCy_R166 spaCy_T166 spaCy_T164 pobj agents,like
spaCy_R167 spaCy_T167 spaCy_T168 amod such,as
spaCy_R168 spaCy_T168 spaCy_T166 prep as,agents
spaCy_R169 spaCy_T169 spaCy_T168 pobj MMC,as
spaCy_R17 spaCy_T17 spaCy_T16 prep of,effect
spaCy_R170 spaCy_T170 spaCy_T169 punct ",",MMC
spaCy_R171 spaCy_T171 spaCy_T172 compound Diketocoriolin,B
spaCy_R172 spaCy_T172 spaCy_T169 conj B,MMC
spaCy_R173 spaCy_T173 spaCy_T172 punct ",",B
spaCy_R174 spaCy_T174 spaCy_T172 conj Carbazilquinon,B
spaCy_R175 spaCy_T175 spaCy_T174 punct ",",Carbazilquinon
spaCy_R176 spaCy_T176 spaCy_T174 conj Endoxan,Carbazilquinon
spaCy_R177 spaCy_T177 spaCy_T176 punct ",",Endoxan
spaCy_R178 spaCy_T178 spaCy_T176 cc and,Endoxan
spaCy_R179 spaCy_T179 spaCy_T176 conj 5-Fluorouracil,Endoxan
spaCy_R18 spaCy_T18 spaCy_T19 quantmod 6-keto-prostaglandin,E1
spaCy_R180 spaCy_T180 spaCy_T183 punct ",",inhibit
spaCy_R181 spaCy_T181 spaCy_T183 aux can,inhibit
spaCy_R182 spaCy_T182 spaCy_T183 advmod significantly,inhibit
spaCy_R183 spaCy_T183 spaCy_T161 ccomp inhibit,conclude
spaCy_R184 spaCy_T184 spaCy_T183 dobj growth,inhibit
spaCy_R185 spaCy_T185 spaCy_T184 prep of,growth
spaCy_R186 spaCy_T186 spaCy_T188 compound AH-130,cells
spaCy_R187 spaCy_T187 spaCy_T188 compound tumor,cells
spaCy_R188 spaCy_T188 spaCy_T185 pobj cells,of
spaCy_R189 spaCy_T189 spaCy_T184 prep in,growth
spaCy_R19 spaCy_T19 spaCy_T17 pobj E1,of
spaCy_R190 spaCy_T190 spaCy_T189 pobj vivo,in
spaCy_R191 spaCy_T191 spaCy_T183 punct ",",inhibit
spaCy_R192 spaCy_T192 spaCy_T194 advmod particularly,administered
spaCy_R193 spaCy_T193 spaCy_T194 advmod when,administered
spaCy_R194 spaCy_T194 spaCy_T183 advcl administered,inhibit
spaCy_R195 spaCy_T195 spaCy_T194 prep in,administered
spaCy_R196 spaCy_T196 spaCy_T195 pobj combination,in
spaCy_R197 spaCy_T197 spaCy_T194 prep with,administered
spaCy_R198 spaCy_T198 spaCy_T200 det the,agent
spaCy_R199 spaCy_T199 spaCy_T200 amod anti-tumor,agent
spaCy_R2 spaCy_T2 spaCy_T3 amod 6-keto-prostaglandin,E1
spaCy_R20 spaCy_T20 spaCy_T21 punct (,pGE1
spaCy_R200 spaCy_T200 spaCy_T197 pobj agent,with
spaCy_R201 spaCy_T201 spaCy_T200 appos MMC,agent
spaCy_R202 spaCy_T202 spaCy_T161 punct .,conclude
spaCy_R21 spaCy_T21 spaCy_T16 appos pGE1,effect
spaCy_R22 spaCy_T22 spaCy_T21 punct ),pGE1
spaCy_R23 spaCy_T23 spaCy_T21 prep on,pGE1
spaCy_R24 spaCy_T24 spaCy_T25 det the,growth
spaCy_R25 spaCy_T25 spaCy_T23 pobj growth,on
spaCy_R26 spaCy_T26 spaCy_T25 cc and,growth
spaCy_R27 spaCy_T27 spaCy_T25 conj survival,growth
spaCy_R28 spaCy_T28 spaCy_T27 prep of,survival
spaCy_R29 spaCy_T29 spaCy_T30 amod ascitic,hepatoma
spaCy_R3 spaCy_T3 spaCy_T1 pobj E1,of
spaCy_R30 spaCy_T30 spaCy_T28 pobj hepatoma,of
spaCy_R31 spaCy_T31 spaCy_T32 punct (,AH-130
spaCy_R32 spaCy_T32 spaCy_T30 appos AH-130,hepatoma
spaCy_R33 spaCy_T33 spaCy_T30 punct ),hepatoma
spaCy_R34 spaCy_T34 spaCy_T27 conj cells,survival
spaCy_R35 spaCy_T35 spaCy_T25 prep in,growth
spaCy_R36 spaCy_T36 spaCy_T35 pobj vivo,in
spaCy_R37 spaCy_T37 spaCy_T38 auxpass was,compared
spaCy_R38 spaCy_T38 spaCy_T38 ROOT compared,compared
spaCy_R39 spaCy_T39 spaCy_T38 prep with,compared
spaCy_R4 spaCy_T4 spaCy_T3 prep on,E1
spaCy_R40 spaCy_T40 spaCy_T41 advmod currently,used
spaCy_R41 spaCy_T41 spaCy_T43 amod used,agents
spaCy_R42 spaCy_T42 spaCy_T43 amod chemotherapeutic,agents
spaCy_R43 spaCy_T43 spaCy_T39 pobj agents,with
spaCy_R44 spaCy_T44 spaCy_T38 punct .,compared
spaCy_R45 spaCy_T45 spaCy_T46 nummod Three,days
spaCy_R46 spaCy_T46 spaCy_T47 npadvmod days,after
spaCy_R47 spaCy_T47 spaCy_T66 prep after,injected
spaCy_R48 spaCy_T48 spaCy_T47 pcomp receiving,after
spaCy_R49 spaCy_T49 spaCy_T51 det an,injection
spaCy_R5 spaCy_T5 spaCy_T6 amod ascitic,hepatoma-130
spaCy_R50 spaCy_T50 spaCy_T51 amod intraperitoneal,injection
spaCy_R51 spaCy_T51 spaCy_T48 dobj injection,receiving
spaCy_R52 spaCy_T52 spaCy_T51 prep of,injection
spaCy_R53 spaCy_T53 spaCy_T61 nummod 3,cells
spaCy_R54 spaCy_T54 spaCy_T61 nmod X,cells
spaCy_R55 spaCy_T55 spaCy_T54 nummod 10,X
spaCy_R56 spaCy_T56 spaCy_T57 punct (,6
spaCy_R57 spaCy_T57 spaCy_T54 appos 6,X
spaCy_R58 spaCy_T58 spaCy_T54 punct ),X
spaCy_R59 spaCy_T59 spaCy_T61 compound AH-130,cells
spaCy_R6 spaCy_T6 spaCy_T4 pobj hepatoma-130,on
spaCy_R60 spaCy_T60 spaCy_T61 compound tumor,cells
spaCy_R61 spaCy_T61 spaCy_T52 pobj cells,of
spaCy_R62 spaCy_T62 spaCy_T66 punct ",",injected
spaCy_R63 spaCy_T63 spaCy_T64 compound Donrhyu,rats
spaCy_R64 spaCy_T64 spaCy_T66 nsubjpass rats,injected
spaCy_R65 spaCy_T65 spaCy_T66 auxpass were,injected
spaCy_R66 spaCy_T66 spaCy_T66 ROOT injected,injected
spaCy_R67 spaCy_T67 spaCy_T66 advmod intravenously,injected
spaCy_R68 spaCy_T68 spaCy_T67 cc or,intravenously
spaCy_R69 spaCy_T69 spaCy_T67 conj intraperitoneally,intravenously
spaCy_R7 spaCy_T7 spaCy_T0 prep in,Effects
spaCy_R70 spaCy_T70 spaCy_T66 prep with,injected
spaCy_R71 spaCy_T71 spaCy_T70 pobj one,with
spaCy_R72 spaCy_T72 spaCy_T71 prep of,one
spaCy_R73 spaCy_T73 spaCy_T74 det the,following
spaCy_R74 spaCy_T74 spaCy_T72 pobj following,of
spaCy_R75 spaCy_T75 spaCy_T74 punct :,following
spaCy_R76 spaCy_T76 spaCy_T77 compound Thromboxane,B2
spaCy_R77 spaCy_T77 spaCy_T74 appos B2,following
spaCy_R78 spaCy_T78 spaCy_T77 punct (,B2
spaCy_R79 spaCy_T79 spaCy_T77 appos TXB2,B2
spaCy_R8 spaCy_T8 spaCy_T9 amod vivo,comparison
spaCy_R80 spaCy_T80 spaCy_T74 punct ),following
spaCy_R81 spaCy_T81 spaCy_T83 punct (,mg/kg
spaCy_R82 spaCy_T82 spaCy_T83 nummod 0.5,mg/kg
spaCy_R83 spaCy_T83 spaCy_T74 appos mg/kg,following
spaCy_R84 spaCy_T84 spaCy_T83 punct ),mg/kg
spaCy_R85 spaCy_T85 spaCy_T74 punct ",",following
spaCy_R86 spaCy_T86 spaCy_T74 appos 6-keto-pGE1,following
spaCy_R87 spaCy_T87 spaCy_T89 punct (,mg/kg
spaCy_R88 spaCy_T88 spaCy_T89 nummod 0.5,mg/kg
spaCy_R89 spaCy_T89 spaCy_T86 parataxis mg/kg,6-keto-pGE1
spaCy_R9 spaCy_T9 spaCy_T7 pobj comparison,in
spaCy_R90 spaCy_T90 spaCy_T89 punct ),mg/kg
spaCy_R91 spaCy_T91 spaCy_T86 punct ",",6-keto-pGE1
spaCy_R92 spaCy_T92 spaCy_T93 compound Mitomycin,C
spaCy_R93 spaCy_T93 spaCy_T105 nmod C,6-keto-pGE1
spaCy_R94 spaCy_T94 spaCy_T93 punct (,C
spaCy_R95 spaCy_T95 spaCy_T93 appos MMC,C
spaCy_R96 spaCy_T96 spaCy_T93 punct ),C
spaCy_R97 spaCy_T97 spaCy_T99 punct (,mg/kg
spaCy_R98 spaCy_T98 spaCy_T99 nummod 1.5,mg/kg
spaCy_R99 spaCy_T99 spaCy_T93 appos mg/kg,C